Effects of Soy Isoflavones on Markers of Bone Turnover in Premenopausal and Postmenopausal Women*

Kerry E. Wangen, Mindy S. Kurzer(University of Minnesota), Robert Marcus(Stanford University), Barb E. Merz-Demlow(University of Minnesota), Alison M. Duncan(University of Minnesota), Xia Xu(Science Applications International Corporation (United States)), William R. Phipps(University of Rochester)
The Journal of Clinical Endocrinology & Metabolism
September 1, 2000
10.1210/jcem.85.9.6787
Cited by 158

Related Papers

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
|PubMed|2002|1k
DIETARY PHYTOESTROGENS
|Annual Review of Nutrition|1997|832
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial
|JAMA|1995|605
Estrogen metabolism and breast cancer
|Cancer Letters|2014|389
Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes
|The Journal of Steroid Biochemistry and Molecular Biology|1994|321